Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Pregnant women without legal status 'too afraid to seek NHS care'

    Growing number of women who fear being reported to Home Office or being hit with high bills are avoiding NHS, charities say.

    21 March 2017 | The Guardian
  • Drugs costing 8p a day could be hit by 'devastating' NHS rationing plan

    At present, the NHS has 90 days to make drugs available to patients, once they have been given the green light by the National Institute of Health and Care Excellence (Nice). The new system will allow health officials an extra three years to introduce drugs, during which time they will try to negotiate cost reductions.

    16 March 2017 | Telegraph
  • Malaysia: MOH to propose importing generic Hepatitis C meds

    The Health Ministry will table a working paper to the Cabinet committee for approval to import of generic drugs to treat Hepatitis C.

    14 March 2017 | Malay Mail Online
  • Will House Republican's Trump-Inspired AHCA 'Make HIV AIDS Again?'

    On March 6, House Republicans released the American Health Care Act (AHCA) to show how they propose to repeal and reform the Affordable Care Act (ACA), aka Obamacare. Major groups such as the American Medical Association (AMA) and the American Association of Retired People (AARP) are not loving it, to say the least. And the reviews from the HIV community? Well, yeah, also not good.

    10 March 2017 | The Body
  • 'I bought hepatitis C cure from Bangladesh'

    Zoe Sharam bought a hepatitis C cure, deemed too expensive for her by the NHS, online from Bangladesh. She speaks to the BBC's Victoria Derbyshire programme.

    02 March 2017 | BBC Health
  • Hepatitis C drugs re-energize global fight over patents

    The liver disease hepatitis C is the new battleground for lawsuits intended to slash the cost of life-saving medicines. In February alone, five suits were filed in India and Argentina claiming that the latest class of antiviral drugs does not warrant the 20-year patent monopoly that manufacturers have sought in those countries.

    01 March 2017 | Nature
  • The Medicines Patents Pool Publishes 2017 Prioritization Report Targeting New HIV and Hepatitis C Medicines for In-licensing

    The Medicines Patent Pool released its 2017 prioritization report today selecting five HIV and two hepatitis C compounds for potential licensing agreements. The annual medicines priority report, traditionally reviewing MPP’s target list for HIV, this year expands to important treatments for the hepatitis C virus (HCV).

    28 February 2017 | Medicines Patent Pool
  • Ukraine signs amicable agreement with Gilead on hepatitis C drug

    Ukraine has signed an amicable agreement with U.S. Gilead Sciences, Inc. biopharmaceutical company on the Sovaldi medicine used to treat chronic hepatitis C infection in adults, acting Ukrainian Health Minister Ulana Suprun said at a press conference on Wednesday. The whole course of hepatitis C treatment with the use of Sovaldi in Ukraine will cost about $750.

    27 February 2017 | Interfax Ukraine
  • Meet The Man Who Stopped Thousands Of People Becoming HIV-Positive

    “I knew I was doing something of substance, but it’s really overwhelming.” In an exclusive interview with BuzzFeed News, Greg Owen reveals the story behind Britain’s largest ever drop in HIV transmissions.

    26 February 2017 | BuzzFeed News
  • Egypt targets hepatitis C patients for medical tourism

    In mid 2016, Prime Pharma, a private Egyptian pharmaceutical company, launched Tour n’ Cure to revive therapeutic tourism in Egypt. The first target is hepatitis C patients from around the world. Countries targeted are Spain, Belgium, Italy, Netherlands and the UK.

    24 February 2017 | International Medical Tourism Journal
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.